Search Within

Romel Somwar

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (42)
  2. Meeting Abstract (41)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (85)
  2. GSK Faculty (85)
  3. Human Oncology and Pathogenesis Program (85)
  4. Sloan Kettering Institute Postdocs (85)
  5. Tow Center for Developmental Oncology (TCDO) (85)
  6. Department of Medicine (53)

More Groups

People
  1. Marc Ladanyi (85)
  2. Alexander Drilon (37)
  3. Elisa De Stanchina (33)
  4. Marissa Mattar (30)
  5. Gregory Riely (26)
  6. Inna Khodos (25)

More People

Years
  1. 2025 (2)
  2. 2024 (10)
  3. 2023 (5)
  4. 2022 (15)
  5. 2021 (11)
  6. 2020 (4)

More Years

Publications
  1. Journal of Thoracic Oncology (20)
  2. Clinical Cancer Research (15)
  3. Journal of Clinical Oncology (9)
  4. Cancer Research (7)
  5. Cancer Discovery (3)
  6. JCO Precision Oncology (3)

More Publications

Publishers
  1. American Association for Cancer Research (27)
  2. Elsevier Inc. (22)
  3. American Society of Clinical Oncology (13)
  4. Nature Publishing Group (5)
  5. Oxford University Press (4)
  6. Nature Research (3)

More Publishers

Results (85)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapeutic potential of NTRK3 in desmoplastic small round cell tumor
    Meeting Abstract

    Spraggon, L.; Hmeljak, J.; Magnan, H.; Somwar, R.; Asher, M.; Hartono, A. B.; Lee, S. B.; Ladanyi, M.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • RASA1 and NF1 co-mutated non-small cell lung carcinomas: Cancer genomic data and evaluation of sensitivity to MEK inhibition
    Meeting Abstract

    Hayashi, T.; Desmeules, P.; Smith, R.; Drilon, A. E.; Somwar, R.; Ladanyi, M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase 2 study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Somwar, R.; Smith, R.; Delasos, L.; Albano, M.; Van Voorthuyson, M.; Wang, L.; Rekhtman, N.; Ni, A.; Plodkowski, A.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Antitumor activity of RXDX-105 in multiple cancer types with RET rearrangements or mutations
    Journal Article

    Li, G. G.; Somwar, R.; Joseph, J.; Smith, R. S.; Hayashi, T.; Martin, L.; Franovic, A.; Schairer, A.; Martin, E.; Riely, G. J.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • MDM2 amplification (Amp) to mediate cabozantinib resistance in patients (Pts) with advanced RET-rearranged lung cancers
    Meeting Abstract

    Somwar, R.; Smith, R.; Hayashi, T.; Ishizawa, K.; Charen, A. S.; Khodos, I.; Mattar, M.; He, J.; Balasubramanian, S.; Stephens, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
    Journal Article

    Drilon, A.; Rekhtman, N.; Arcila, M.; Wang, L.; Ni, A.; Albano, M.; Van Voorthuysen, M.; Somwar, R.; Smith, R. S.; Montecalvo, J.; more...
    Lancet Oncology (2016)

    Fulltext@MSK | Save
  • Proteasome addiction defined in Ewing sarcoma is effectively targeted by a novel class of 19S proteasome inhibitors
    Journal Article

    Shukla, N.; Somwar, R.; Smith, R. S.; Ambati, S.; Munoz, S.; Merchant, M.; D'Arcy, P.; Wang, X.; Kobos, R.; Antczak, C.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers
    Journal Article

    Drilon, A.; Bergagnini, I.; Delasos, L.; Sabari, J.; Woo, K. M.; Plodkowski, A.; Wang, L.; Hellmann, M. D.; Joubert, P.; Sima, C. S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • A novel crizotinib-resistant solvent-front mutation responsive to cabozantinib therapy in a patient with ROS1-rearranged lung cancer
    Journal Article

    Drilon, A.; Somwar, R.; Wagner, J. P.; Vellore, N. A.; Eide, C. A.; Zabriskie, M. S.; Arcila, M. E.; Hechtman, J. F.; Wang, L.; Smith, R. S.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A. E.; Sima, C. S.; Somwar, R.; Smith, R.; Ginsberg, M. S.; Riely, G. J.; Rudin, C. M.; Ladanyi, M.; Kris, M. G.; Rizvi, N. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save